US EditionIn UK filing, AstraZeneca admits for first time its COVID vaccine can cause rare side effect
- AstraZeneca publicly acknowledged the rare side effect of its COVID-19 vaccine for the first time.
- The company admitted in legal documents to the UK High Court that the vaccine can lead to Thrombosis with Thrombocytopenia Syndrome .
- The admission might result in a substantial legal compensation, according to the Telegraph.
84 Articles
84 Articles
AstraZeneca's Covid vaccine is being withdrawn worldwide, months after the pharmaceutical giant admitted for the first time in court documents that it can cause a rare and dangerous side effect, the Telegraph reported.
AstraZeneca announces it will stop selling the COVID-19 vaccine in Europe as the drug, originally known as Oxford or Covishield, is not a central part of its business currently. The move comes days after the company declared in an English court that the drug can cause blood clots.
AstraZeneca Admits in Court Documents That COVID-19 Vaccine Could Cause Serious Rare Side Effect
by Misty Severi British pharmaceutical company AstraZeneca admitted in court documents for the first time that its COVID-19 vaccine could cause a rare blood-clotting side effect. The company is facing accusations that its vaccine contributed to the deaths or impairments of more than 50 people in the United Kingdom whose family are suing the pharmaceutical company. One claimant named Jamie Scott alleged the vaccine caused a permanent brain inju…
Coverage Details
Bias Distribution
- 69% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
